Extracellular Vesicles in ALS: BRAVYL’s Role in Reducing TDP-43 Pathology and Disease Spread

December 10, 2024 Leave a comment

Woolsey Pharmaceuticals, a clinical-stage pharmaceutical company developing BRAVYL (oral fasudil) for the treatment of Amyotrophic Lateral Sclerosis (ALS), announced that a poster by Dr. Daniel Linseman’s laboratory at the University of...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: BRAVYL treatment

Extracellular Vesicles in ALS: BRAVYL’s Role in Reducing TDP-43 Pathology and Disease Spread

Researchers find way to treat lung cancer and associated muscle wasting at the same time

Engineered extracellular vesicles can learn from decades of liposome research

Exercise-enriched extracellular vesicles may help maintain aging cartilage

Everest Biolabs Awarded $2.1 Million NIH SBIR Grant to Advance Extracellular Vesicle Biomarker Discovery at Scale with High-Purity, High-Throughput Isolation

An anti-fibrotic drug could be repurposed to control cell communication

Electronic profiling of neuronal extracellular vesicles enables early prediction of Parkinson’s disease